{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:53:50Z","timestamp":1785552830499,"version":"3.56.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Associazione Italiana per la Ricerca sul Cancro, Milan, Italy","award":["AIRC project IG 2020 - ID. 24566"],"award-info":[{"award-number":["AIRC project IG 2020 - ID. 24566"]}]},{"name":"Argentinean National Agency of Promotion of Science and Technology","award":["PICT 2019-1448"],"award-info":[{"award-number":["PICT 2019-1448"]}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"crossref","award":["ASH Global Research Award"],"award-info":[{"award-number":["ASH Global Research Award"]}],"id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91536-5","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T03:26:31Z","timestamp":1740367591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["G-protein coupled receptor kinase-2 regulates the migration of chronic lymphocytic leukaemia cells to sphingosine-1 phosphate in vitro and their trafficking in vivo"],"prefix":"10.1038","volume":"15","author":[{"given":"Mar\u00eda Chiara","family":"Cassarino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Colado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Sarapura","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Martines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Bonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Pavlovksy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Custidiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Raimundo","family":"Bezares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo El\u00edas","family":"Morande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Gamberale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirta","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitar G","family":"Efremov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Borge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"issue":"5","key":"91536_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/ajh.23979","volume":"90","author":"M Hallek","year":"2015","unstructured":"Hallek, M. Chronic lymphocytic leukemia: 2015 update on diagnosis, risk stratification, and treatment. Am. J. Hematol. 90 (5), 446\u2013460 (2015).","journal-title":"Am. J. Hematol."},{"issue":"2","key":"91536_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","volume":"117","author":"Y Herishanu","year":"2011","unstructured":"Herishanu, Y. et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 117 (2), 563\u2013574 (2011).","journal-title":"Blood"},{"issue":"8","key":"91536_CR3","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","volume":"96","author":"JA Burger","year":"2000","unstructured":"Burger, J. A. et al. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 96 (8), 2655\u20132663 (2000).","journal-title":"Blood"},{"issue":"10","key":"91536_CR4","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1182\/blood-2007-08-108605","volume":"111","author":"PE Patten","year":"2008","unstructured":"Patten, P. E. et al. CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood 111 (10), 5173\u20135181 (2008).","journal-title":"Blood"},{"issue":"13","key":"91536_CR5","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1182\/blood-2008-03-146704","volume":"112","author":"DY Hallaert","year":"2008","unstructured":"Hallaert, D. Y. et al. c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches. Blood 112 (13), 5141\u20135149 (2008).","journal-title":"Blood"},{"issue":"18","key":"91536_CR6","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1182\/blood-2008-08-173310","volume":"113","author":"M Vogler","year":"2009","unstructured":"Vogler, M. et al. Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. Blood 113 (18), 4403\u20134413 (2009).","journal-title":"Blood"},{"issue":"25","key":"91536_CR7","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1182\/blood-2015-10-675009","volume":"127","author":"K Bojarczuk","year":"2016","unstructured":"Bojarczuk, K. et al. BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199. Blood 127 (25), 3192\u20133201 (2016).","journal-title":"Blood"},{"issue":"5","key":"91536_CR8","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.3109\/10428194.2014.991731","volume":"56","author":"F Boissard","year":"2015","unstructured":"Boissard, F., Fournie, J. J., Laurent, C., Poupot, M. & Ysebaert, L. Nurse like cells: chronic lymphocytic leukemia associated macrophages. Leuk. Lymphoma. 56 (5), 1570\u20131572 (2015).","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"91536_CR9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3109\/10428194.2011.610014","volume":"53","author":"RE Hayden","year":"2011","unstructured":"Hayden, R. E., Pratt, G., Roberts, C., Drayson, M. T. & Bunce, C. M. Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches. Leuk. Lymphoma. 53 (4), 537\u2013549 (2011).","journal-title":"Leuk. Lymphoma"},{"issue":"8","key":"91536_CR10","first-page":"e302","volume":"100","author":"R Thijssen","year":"2015","unstructured":"Thijssen, R. et al. Resistance to ABT-199 induced by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors. Haematologica 100 (8), e302\u2013e306 (2015).","journal-title":"Haematologica"},{"key":"91536_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-immunol-020711-075011","volume":"30","author":"JG Cyster","year":"2012","unstructured":"Cyster, J. G. & Schwab, S. R. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 30, 69\u201394 (2012).","journal-title":"Annu. Rev. Immunol."},{"issue":"6051","key":"91536_CR12","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1126\/science.1208248","volume":"333","author":"TI Arnon","year":"2011","unstructured":"Arnon, T. I. et al. GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood. Science 333 (6051), 1898\u20131903 (2011).","journal-title":"Science"},{"issue":"10","key":"91536_CR13","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nri2400","volume":"8","author":"J Rivera","year":"2008","unstructured":"Rivera, J., Proia, R. L. & Olivera, A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat. Rev. Immunol. 8 (10), 753\u2013763 (2008).","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"91536_CR14","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.4049\/jimmunol.1900678","volume":"203","author":"IY Hwang","year":"2019","unstructured":"Hwang, I. Y., Park, C., Harrison, K. & Kehrl, J. H. Biased S1PR1 signaling in B cells subverts responses to homeostatic chemokines, severely disorganizing lymphoid organ architecture. J. Immunol. 203 (9), 2401\u20132414 (2019).","journal-title":"J. Immunol."},{"issue":"6","key":"91536_CR15","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.4049\/jimmunol.1400547","volume":"193","author":"M Borge","year":"2014","unstructured":"Borge, M. et al. The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by Piceatannol and R406. J. Immunol. 193 (6), 3165\u20133174 (2014).","journal-title":"J. Immunol."},{"issue":"19","key":"91536_CR16","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1158\/0008-5472.CAN-15-0986","volume":"75","author":"L Patrussi","year":"2015","unstructured":"Patrussi, L. et al. Enhanced chemokine receptor recycling and impaired S1P1 expression promote leukemic cell infiltration of lymph nodes in chronic lymphocytic leukemia. Cancer Res. 75 (19), 4153\u20134163 (2015).","journal-title":"Cancer Res."},{"issue":"22","key":"91536_CR17","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1182\/blood-2012-04-425959","volume":"120","author":"N Capitani","year":"2012","unstructured":"Capitani, N. et al. S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis. Blood 120 (22), 4391\u20134399 (2012).","journal-title":"Blood"},{"key":"91536_CR18","doi-asserted-by":"crossref","unstructured":"Chakraborty, S. et al. B cell receptor signaling and genetic lesions in TP53 and CDKN2A\/CDKN2B cooperate in Richter transformation. Blood Apr 30. (2021).","DOI":"10.1182\/blood.2020008276"},{"issue":"9","key":"91536_CR19","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1093\/nar\/gkv126","volume":"43","author":"Z Yang","year":"2015","unstructured":"Yang, Z. et al. Fast and sensitive detection of indels induced by precise gene targeting. Nucleic Acids Res. 43 (9), e59 (2015).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"91536_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1677\/JOE-07-0562","volume":"198","author":"T Metaye","year":"2008","unstructured":"Metaye, T., Levillain, P., Kraimps, J. L. & Perdrisot, R. Immunohistochemical detection, regulation and antiproliferative function of G-protein-coupled receptor kinase 2 in thyroid carcinomas. J. Endocrinol. 198 (1), 101\u2013110 (2008).","journal-title":"J. Endocrinol."},{"key":"91536_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ebiom.2016.09.030","volume":"13","author":"L Nogues","year":"2016","unstructured":"Nogues, L. et al. G Protein-coupled receptor kinase 2 (GRK2) promotes breast tumorigenesis through a HDAC6-Pin1 Axis. EBioMedicine 13, 132\u2013145 (2016).","journal-title":"EBioMedicine"},{"key":"91536_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.humpath.2016.06.012","volume":"56","author":"L Zhou","year":"2016","unstructured":"Zhou, L. et al. G-protein-coupled receptor kinase 2 in pancreatic cancer: clinicopathologic and prognostic significance. Hum. Pathol. 56, 171\u2013177 (2016).","journal-title":"Hum. Pathol."},{"issue":"9","key":"91536_CR23","doi-asserted-by":"publisher","first-page":"e1005171","DOI":"10.1371\/journal.ppat.1005171","volume":"11","author":"M Hu","year":"2015","unstructured":"Hu, M. et al. A KSHV MicroRNA directly targets G Protein-Coupled receptor kinase 2 to promote the migration and invasion of endothelial cells by inducing CXCR2 and activating AKT signaling. PLoS Pathog. 11 (9), e1005171 (2015).","journal-title":"PLoS Pathog."},{"issue":"2","key":"91536_CR24","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1172\/JCI97040","volume":"130","author":"J Cheng","year":"2020","unstructured":"Cheng, J. et al. GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein. J. Clin. Investig. 130 (2), 1036\u20131051 (2020).","journal-title":"J. Clin. Investig."},{"issue":"6","key":"91536_CR25","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.3324\/haematol.2015.138172","volume":"101","author":"K Filarsky","year":"2016","unstructured":"Filarsky, K. et al. Kruppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by Inhibition of NOTCH signaling. Haematologica 101 (6), e249\u2013e253 (2016).","journal-title":"Haematologica"},{"issue":"16","key":"91536_CR26","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1182\/blood-2010-02-269878","volume":"116","author":"A Gutierrez Jr","year":"2010","unstructured":"Gutierrez, A. Jr. et al. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. Blood 116 (16), 2975\u20132983 (2010).","journal-title":"Blood"},{"issue":"1","key":"91536_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/CBM-2012-0259","volume":"11","author":"A Trojani","year":"2011","unstructured":"Trojani, A. et al. Gene expression profiling identifies ARSD as a new marker of disease progression and the sphingolipid metabolism as a potential novel metabolism in chronic lymphocytic leukemia. Cancer Biomarkers : Sect. Disease Markers. 11 (1), 15\u201328 (2011).","journal-title":"Cancer Biomarkers : Sect. Disease Markers"},{"issue":"6","key":"91536_CR28","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3324\/haematol.2008.002626","volume":"94","author":"B Stamatopoulos","year":"2009","unstructured":"Stamatopoulos, B. et al. Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA. Haematologica 94 (6), 790\u2013799 (2009).","journal-title":"Haematologica"},{"issue":"16","key":"91536_CR29","doi-asserted-by":"publisher","first-page":"eadf6059","DOI":"10.1126\/sciadv.adf6059","volume":"9","author":"A Radoux-Mergault","year":"2023","unstructured":"Radoux-Mergault, A., Oberhauser, L., Aureli, S., Gervasio, F. L. & Stoeber, M. Subcellular location defines GPCR signal transduction. Sci. Adv. 9 (16), eadf6059 (2023).","journal-title":"Sci. Adv."},{"issue":"2","key":"91536_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1124\/mol.115.098293","volume":"88","author":"JD Lowe","year":"2015","unstructured":"Lowe, J. D. et al. Role of G Protein-Coupled receptor kinases 2 and 3 in mu-Opioid receptor desensitization and internalization. Mol. Pharmacol. 88 (2), 347\u2013356 (2015).","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"91536_CR31","doi-asserted-by":"publisher","first-page":"13902","DOI":"10.1038\/s41598-019-50157-5","volume":"9","author":"AS Pathania","year":"2019","unstructured":"Pathania, A. S., Ren, X., Mahdi, M. Y., Shackleford, G. M. & Erdreich-Epstein, A. GRK2 promotes growth of Medulloblastoma cells and protects them from chemotherapy-induced apoptosis. Sci. Rep. 9 (1), 13902 (2019).","journal-title":"Sci. Rep."},{"issue":"7","key":"91536_CR32","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/s41375-024-02224-8","volume":"38","author":"A Bonato","year":"2024","unstructured":"Bonato, A. et al. NFKBIE mutations are selected by the tumor microenvironment and contribute to immune escape in chronic lymphocytic leukemia. Leukemia 38 (7), 1511\u20131521 (2024).","journal-title":"Leukemia"},{"issue":"17","key":"91536_CR33","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1182\/bloodadvances.2020003944","volume":"5","author":"KD Jayappa","year":"2021","unstructured":"Jayappa, K. D. et al. Extrinsic interactions in the microenvironment in vivo activate an antiapoptotic multidrug-resistant phenotype in CLL. Blood Adv. 5 (17), 3497\u20133510 (2021).","journal-title":"Blood Adv."},{"key":"91536_CR34","doi-asserted-by":"crossref","unstructured":"Pozzo, F. et al. Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia. Leukemia Jun 24. (2024).","DOI":"10.1038\/s41375-024-02301-y"},{"key":"91536_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fphar.2019.00112","volume":"10","author":"C Murga","year":"2019","unstructured":"Murga, C. et al. Jr. G Protein-Coupled receptor kinase 2 (GRK2) as a potential therapeutic target in cardiovascular and metabolic diseases. Front. Pharmacol. 10, 112 (2019).","journal-title":"Front. Pharmacol."},{"issue":"10","key":"91536_CR36","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41569-019-0220-3","volume":"16","author":"J Pfleger","year":"2019","unstructured":"Pfleger, J., Gresham, K. & Koch, W. J. G protein-coupled receptor kinases as therapeutic targets in the heart. Nat. Reviews Cardiol. 16 (10), 612\u2013622 (2019).","journal-title":"Nat. Reviews Cardiol."},{"key":"91536_CR37","doi-asserted-by":"crossref","unstructured":"Han, C. et al. Development of inflammatory immune Response-Related drugs based on G Protein-Coupled receptor kinase 2. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and Pharmacology. ;51(2):729\u2013745. (2018).","DOI":"10.1159\/000495329"},{"key":"91536_CR38","doi-asserted-by":"publisher","first-page":"114668","DOI":"10.1016\/j.ejmech.2022.114668","volume":"243","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Targeting GRK2 and GRK5 for treating chronic degenerative diseases: advances and future perspectives. Eur. J. Med. Chem. 243, 114668 (2022).","journal-title":"Eur. J. Med. Chem."},{"key":"91536_CR39","doi-asserted-by":"publisher","first-page":"1039803","DOI":"10.3389\/fimmu.2022.1039803","volume":"13","author":"KM Glaser","year":"2022","unstructured":"Glaser, K. M., Tarrant, T. K. & Lammermann, T. Combinatorial depletions of G-protein coupled receptor kinases in immune cells identify pleiotropic and cell type-specific functions. Front. Immunol. 13, 1039803 (2022).","journal-title":"Front. Immunol."},{"key":"91536_CR40","doi-asserted-by":"publisher","first-page":"596104","DOI":"10.3389\/fcimb.2021.596104","volume":"11","author":"M Gualdron-Lopez","year":"2021","unstructured":"Gualdron-Lopez, M. et al. Multiparameter flow cytometry analysis of the human spleen applied to studies of Plasma-Derived EVs from plasmodium Vivax patients. Front. Cell. Infect. Microbiol. 11, 596104 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"91536_CR41","doi-asserted-by":"crossref","unstructured":"Lewis, S. M., Williams, A. & Eisenbarth, S. C. Structure and function of the immune system in the spleen. Sci. Immunol. ;4(33). (2019).","DOI":"10.1126\/sciimmunol.aau6085"},{"issue":"5\u20136","key":"91536_CR42","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/10428199009169601","volume":"1","author":"IA Lampert","year":"1990","unstructured":"Lampert, I. A., Hegde, U. & Van Noorden, S. The Splenic white pulp in chronic lymphocytic leukaemia: A microenvironment associated with CR2 (CD21) expression, cell transformation and proliferation. Leuk. Lymphoma. 1 (5\u20136), 319\u2013326 (1990).","journal-title":"Leuk. Lymphoma"},{"issue":"6","key":"91536_CR43","doi-asserted-by":"publisher","first-page":"e2868","DOI":"10.1038\/cddis.2017.263","volume":"8","author":"F Zhang","year":"2017","unstructured":"Zhang, F. et al. EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway. Cell Death Dis. 8 (6), e2868 (2017).","journal-title":"Cell Death Dis."},{"issue":"11","key":"91536_CR44","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1074\/jbc.M112.428078","volume":"288","author":"X Fu","year":"2013","unstructured":"Fu, X., Koller, S., Abd Alla, J. & Quitterer, U. Inhibition of G-protein-coupled receptor kinase 2 (GRK2) triggers the growth-promoting mitogen-activated protein kinase (MAPK) pathway. J. Biol. Chem. 288 (11), 7738\u20137755 (2013).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"91536_CR45","doi-asserted-by":"publisher","first-page":"e0122946","DOI":"10.1371\/journal.pone.0122946","volume":"10","author":"M Buchholz","year":"2015","unstructured":"Buchholz, M. et al. A multistep high-content screening approach to identify novel functionally relevant target genes in pancreatic cancer. PloS One. 10 (4), e0122946 (2015).","journal-title":"PloS One"},{"issue":"2","key":"91536_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1385\/ENDO:22:2:135","volume":"22","author":"DW King","year":"2003","unstructured":"King, D. W. et al. Differential expression of GRK isoforms in nonmalignant and malignant human granulosa cells. Endocrine 22 (2), 135\u2013142 (2003).","journal-title":"Endocrine"},{"issue":"5","key":"91536_CR47","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1182\/blood.2022016600","volume":"142","author":"JK Khalsa","year":"2023","unstructured":"Khalsa, J. K. et al. Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples. Blood 142 (5), 421\u2013433 (2023).","journal-title":"Blood"},{"key":"91536_CR48","doi-asserted-by":"crossref","unstructured":"Ondrisova, L. et al. FoxO1\/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia. J. Clin. Investig. ;134(23). (2024).","DOI":"10.1172\/JCI173770"},{"key":"91536_CR49","doi-asserted-by":"publisher","first-page":"107548","DOI":"10.1016\/j.leukres.2024.107548","volume":"144","author":"C Kong","year":"2024","unstructured":"Kong, C. et al. PI3K\/AKT confers intrinsic and acquired resistance to Pirtobrutinib in chronic lymphocytic leukemia. Leuk. Res. 144, 107548 (2024).","journal-title":"Leuk. Res."},{"key":"91536_CR50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fphar.2019.00059","volume":"10","author":"S Palikhe","year":"2019","unstructured":"Palikhe, S. et al. Regulatory role of GRK2 in the TLR Signaling-Mediated iNOS induction pathway in microglial cells. Front. Pharmacol. 10, 59 (2019).","journal-title":"Front. Pharmacol."},{"issue":"1","key":"91536_CR51","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41375-019-0507-8","volume":"34","author":"N Gimenez","year":"2020","unstructured":"Gimenez, N. et al. Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia. Leukemia 34 (1), 100\u2013114 (2020).","journal-title":"Leukemia"},{"issue":"22","key":"91536_CR52","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1182\/blood.2022016272","volume":"140","author":"C Martines","year":"2022","unstructured":"Martines, C. et al. Macrophage- and BCR-derived but not TLR-derived signals support the growth of CLL and Richter syndrome murine models in vivo. Blood 140 (22), 2335\u20132347 (2022).","journal-title":"Blood"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91536-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91536-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91536-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T03:26:43Z","timestamp":1740367603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91536-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91536"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91536-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MP received honoraria from: AstraZeneca, Janssen and Merck. The remaining authors declare no competing financial interests regarding this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"6530"}}